Comparison Chart Monopar Therapeutics Inc.
Stocks
MNPR
US61023L2079
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
23:00:00 06/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 79.57 USD | +1.63% |
|
-0.54% | +21.85% |
| 10-06 | Monopar Therapeutics Insider Sold Shares Worth $659,387, According to a Recent SEC Filing | MT |
| 09-21 | Monopar Therapeutics Inc.(NasdaqCM:MNPR) added to S&P Biotechnology Select Industry Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MONOPAR THERAPEUTICS INC. | Other Biotechnology & Medical Research | +1.63% | -0.54% | +21.85% | -20.03% | +249.76% | 534M |  |  | |
- Stock Market
- Stocks
- MNPR Stock
- Charts Monopar Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
